Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Implementation

Authors

Mohamed Azab, University of Nevada, Las VegasFollow
Sayed Shah, University of Nevada, Las VegasFollow
Xibei Liu, University of ArizonaFollow
Amaan Shafi, University of Nevada, Las VegasFollow
Tamarah Al Dawoodi, University of Nevada, Las VegasFollow
Yousif Elmofti, University of Nevada, Las VegasFollow
Mary Froehlich, University of Nevada Reno School of MedicineFollow
Johnson Ukken, University of Nevada Reno School of MedicineFollow
Ji Won Yoo, University of Nevada, Las VegasFollow

Document Type

Article

Publication Date

3-1-2018

Publication Title

Transplantation

Volume

102

Issue

3

First page number:

e122

Last page number:

e123

Keywords

Immunology; Surgery; Transplantation

Disciplines

Medicine and Health Sciences

Language

English

Repository Citation

Azab, M., Shah, S., Liu, X., Shafi, A., Al Dawoodi, T., Elmofti, Y., Froehlich, M., Ukken, J., Yoo, J. (2018). Necessity of Interrupted Time Series Analysis in Evaluating the Impact of PHS Risk Identification and Introduction of Direct-Acting Antiviral Therapy and Share 35 Implementation. Transplantation, 102(3), e122-e123.
http://dx.doi.org/10.1097/TP.0000000000002040